BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ChromaDex, Inc. 

10005 Muirlands Boulevard
Suite G, First Floor
Irvine  California  92618  U.S.A.
Phone: 949-419-0288 Fax: 949-419-0294


SEARCH JOBS




Industry
Biotechnology






 Company News
ChromaDex, Inc. Reports Second Quarter Ingredient Sales Grew 155% Year-Over-Year And 52% Sequentially 8/12/2014 9:22:38 AM
ChromaDex, Inc.'s Ryan Dellinger To Speak At 248th American Chemical Society National Meeting 8/6/2014 10:04:52 AM
ChromaDex, Inc. Signs Material Transfer Agreement With Prominent Australian Research Institute For NIAGEN™ Research 7/31/2014 8:03:21 AM
ChromaDex, Inc. Initiates First Human Clinical Study To Confirm ChromaDex's NIAGEN™ Nicotinamide Riboside Will Increase NAD+ 7/16/2014 9:36:35 AM
Nobel Laureate Roger Kornberg To Chair New ChromaDex, Inc. Scientific Advisory Board 7/8/2014 10:22:51 AM
ChromaDex, Inc. Signs Collaboration Research Agreement With St. Jude Children's Research Hospital 6/19/2014 6:59:32 AM
ChromaDex, Inc. Licenses Exclusive Patent Rights From Dartmouth College For Pharmaceutical Use Of Nicotinamide Riboside (NR) 6/3/2014 9:18:58 AM
ChromaDex, Inc. CEO To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/30/2014 7:10:20 AM
ChromaDex, Inc. And JQMS Announce Exclusive Sales And Marketing Agreement For GMP Compliance Services 5/28/2014 9:09:45 AM
ChromaDex, Inc. Initiates Second Human Clinical Study For Its Caffeine Ingredient, PURENERGY® 5/14/2014 12:32:51 PM
12345678910